Measuring severity in OSA: the arguments for collaboratively developing a multidimensional score
- S-Med
- Feb 4
- 1 min read
In the sphere of sleep medicine in general, and more particularly in the context of OSA, we are unfortunately dragging behind with regard to the progress realized in the below
-mentioned directions of developing a multidimensional, validated, and pragmatically valuable score when compared with several other major respiratory diseases. We should be conscious that such diseases are all less prevalent than OSA, and yet even though they impose adverse morbidity and mortality consequences that are sometimes less impactful than OSA, they have already benefited from the invested effort required to develop their unique multidimensional scores. Reaching this desirable stage for OSA would obviously be of great benefit. Although it would not permit precision medicine outright, it would still enable what we would term an intermediary stage of “stratified medicine.” The increased prevalence of OSA around the globe, the large number of extant databases, and options for their expansion through natural language exploration of electronic medical records are existing prerequisites for the definite feasibility of developing a uniquely valuable OSA score. “Where there is a need, there is a way” (Albert Einstein).
Comments